Ulcerative colitis-associated neoplasia

Pathology International

Volumn 52, Issue 3, 2002, Pages 195-203

  Fujii, Shigehiko ^a   Fujimori, Takahiro ^a   Kashida, Hiroshi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Colitic cancer; Dysplasia; Genetic changes

Indexed keywords

APC PROTEIN; K RAS PROTEIN; PROTEIN; PROTEIN P16; PROTEIN P53; UNCLASSIFIED DRUG;

CANCER INCIDENCE; CANCER RISK; CHROMOSOME 18Q; CHROMOSOME DELETION; COLON BIOPSY; COLON CARCINOMA; COLONOSCOPY; COLORECTAL CANCER; DYSPLASIA; ENTERITIS; GENE MUTATION; HISTOPATHOLOGY; HUMAN; METHYLATION; ONCOGENE K RAS; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; GENES, DCC; GENES, MCC; HUMANS; MIDDLE AGED; PRECANCEROUS CONDITIONS;

EID: 0036964681     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2002.01333.x     Document Type: Review

References (82)

1. Crohn BB, Rosenberg H. The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am. J. Med. Sci. 1925; 170: 220-228.
2. Dobbins WO III. Dysplasia and malignancy in inflammatory bowel disease. Ann. Rev. Med. 1984;35: 33-48.
3. Levin B. Gastrointestinal neoplasia in inflammatory bowel disease. In: Kirsner JB, Shorter RG, eds. Inflammatory Bowel Disease, 4th edn. Baltimore: Williams and Wilkins, 1995; 461-473.
4. Greenstein AJ, Sachar DB, Smith H et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 1979;77: 290-294.
5. Nugent FW, Haggitt RC, Colcher H, Kutteruf GC. Malignant potential of chronic ulcerative colitis: preliminary report. Gastroenterology 1979;76: 1-5.
6. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Part IV. Carcinoma of the colon. Gut 1964;5: 15-22.
7. Ritchie JK, Hawley PR, Lennard-Jones JE. Prognosis of carcinoma in ulcerative colitis. Gut 1981;22: 752-755.
8. Gyde SN, Prior P, Thompson H, Waterhouse JAH, Allan RN. Survival of patients with colorectal cancer complicating ulcerative colitis. Gut 1984;25: 228-231.
9. Warren S, Sommers SC. Pathogenesis of ulcerative colitis. Am. J. Pathol. 1949;25: 657-679.
10. Morson BC, Pang LSC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967;8: 423-434.
11. Blackstone MO, Riddel RH, Rogers BHG, Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in longstanding ulcerative colitis: an indication for colectomy. Gastroenterology 1981;80: 366-374.
12. Riddel RH, Goldman H, Ransohoff DF et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum. Pathol. 1983; 14: 931-968.
13. Konishi F, Wakasa H, Kino I, Watanabe H, Nagura H, Muto T. Histological Classification of the Neoplastic Epithelium Arising in Ulcerative Colitis. Annual Report (for 1992) of the Research Committee of Inflammatory Bowel Disease. Tokyo: Ministry of Health and Welfare of Japan, 1993; 153-156 (in Japanese with English abstract).
14. Rubin PH, Friedman S, Harpaz N et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999; 117: 1295-1300.
15. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 1999; 117: 1288-1294.
16. Fujimori T, Miura M, Tonariya Y, Tomita T, Nagasako K. Ulcerative colitis complicated with two colonic carcinomas and precarcinomatous lesions, an autopsy case. Stom. Intest. 1980;15: 323-330 (in Japanese with English abstract).
17. Nagasako K, lizuka B, Ishii F, Miyazaki J, Fujimori T. Colonoscopic diagnosis of dysplasia and early cancer in longstanding colitis. J. Gastroenterol. 1995;30: 36-39.
18. Rozen P, Baratz M, Fefer F, Gilat T. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology 1995; 108: 1361-1370.
19. Lindberg B, Persson B, Veress B, Ingelman-Sundberg H, Granqvist S. Twenty years' colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation. Scand. J. Gastroenterol. 1963;1: 1195-1204.
20. Lashner BA. Recommendations for colorectal cancer screening in ulcerative colitis: a review of research from a single University-based surveillance program. Am. J. Gastroenterol. 1992; 87: 168-175.
21. Suzuki K, Muto T, Shinozaki M, Higuchi Y, Sawada T, Saito Y. Results of cancer surveillance in ulcerative colitis. J. Gastroenterol. 1995;30: 40-42.
22. Karlen P, Kornfeld D, Broström O, Löfberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998;42: 711-714.
23. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990;31: 800-806.
24. Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991;100: 1241-1248.
25. Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993;105: 418-424.
26. Taylor BA, Pemberton JH, Carpenter HA et al. Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis. Colon Rectum 1992;35: 950-956.
27. Axon ATR. Surveillance in ulcerative colitis does not work and cannot work. In: Riddell RH, ed. Dysplasia and Cancer in Colitis. New York: Elsevier, 1991; 43-48.
28. Axon ATR. Cancer surveillance in ulcerative colitis - a time for reappraisal. Gut 1994;35: 587-589.
29. Tada M, Kawai K, Niki H, Hattori T, Fujita S. Magnified observation of minute changes of polypoid lesions in the large intestine. Stom. Intest. 1978;13: 625-636 (in Japanese with English abstract).
30. Igarashi M, Ooida M, Atari H et al. Magnifying endoscopic and histopathological findings of the various polypoid lesions in the large intestine. Gastroenterol. Endosc. 1981; 23: 540-550 (in Japanese with English abstract).
31. Kudo S, Miura K, Takano Y, Bannai H. Detection of colorectal minute cancer. Stom. Intest. 1990;25: 801-812 (in Japanese with English abstract).
32. Fujimori T, Kashiwagi R, Nishitani K et al. Comparison of dissecting microscope findings between gastric and colorectal flat type differentiated adenocarcinoma. Endoscopia Digestiva 1995;7: 241-250 (in Japanese with English abstract).
33. Hamilton SR, Vogelstein B, Kudo S et al. Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. Lyon: IARC Press, 2000; 105-119.
34. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N. Eng. J. Med. 1988; 319: 525-532.
35. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260: 816-819.
36. Inovo Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequence reveal a new mechanism for colonic carcinogenesis. Nature 1993;365: 558-561.
37. Leppert M, Dobbs M, Scambler P et al. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 1987;238: 1411-1413.
38. Bodmer WF, Bailey CJ, Bodmer J et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328: 614-616.
39. Kinzler KW, Nilbert MC, Su LK et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661-665.
40. Groden J, Thliveris A, Samowitz W et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66: 589-600.
41. Powell SM, Zilz N, Beazer-Barclay Y et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992;359: 235-237.
42. Greenwald BD, Harpaz N, Yin J et al. Loss of heterozygosity affecting the p53, Rb, and mcc/APC tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res. 1992;52: 741-745.
43. Kern SE, Redston M, Caldas C et al. Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 1994; 107: 420-428.
44. Tarmin L, Yin J, Harpaz N et al. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasia and cancers versus sporadic colon neoplasms. Cancer Res. 1995;55: 2035-2038.
45. Umetani N, Sasaki S, Watanabe T et al. Genetic alterations in ulcerative colitis-associated neoplasia focusing on APC, K-ras gene and microsatellite instability. Jpn. J. Cancer Res. 1999;90: 1081-1087.
46. Fujimori T, Satonaka K, Yamamura-Idei Y, Nagasako K, Maeda S. Non-involvement of ras mutations on flat colorectal adenomas and carcinomas. Int. J. Cancer 1994;57: 51-55.
47. Fujimori T, Ono Y, Sakuma K, Ueda Y, Terano A. Genetic changes in colorectal adenoma and carcinoma in relation to various morphologic aspects. J. Gastroenterol. 1998;33: 804-810.
48. Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE, Rabinovitch PS. c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 1990; 99: 416-420.
49. Bell SM, Kelly SA, Hoyle JA et al. c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br. J. Cancer 1991;64: 174-178.
50. Chen J, Compton C, Cheng E, Fromowitz F, Viola MV. c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis. Gastroenterology 1992;102: 1983-1987.
51. Chaubert P, Benhattar J, Saraga E, Costa J. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am. J. Pathol. 1994;144: 767-775.
52. Holzmann K, Klump B, Borchard F et al. Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis. Int. J. Cancer 1998;76: 1-6.
53. Brachmann RK, Vidal M, Boeke JD. Dominant-negative p53 mutations selected in yeast hit cancer hot spots. Proc. Natl Acad. Sci. USA 1996;93: 4091-4095.
54. Baker SJ, Preisinger AC, Jessup JM et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 1990;50: 7717-7722.
55. Yin J, Harpez N, Tong Y et al. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 1993;104: 1633-1639.
56. Harpaz N, Peck AL, Yin J et al. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum. Pathol. 1994;25: 1069-1074.
57. Brentnall TA, Crispin DA, Rabinovitsch PS et al. Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994;107: 369-378.
58. Toda J, Nagasako K, Fujimori T, Kato Y, Hayashi N. The study of genetic changes in colorectal cancer with ulcerative colitis. Nippon Shokakibyo Gakkai Zasshi 1998; 95: 123-132 (in Japanese with English abstract).
59. Walsh SV, Loda M, Torres CM, Antonioli D, Odze RD. p53 and β-catenin expression in chronic ulcerative colitis-associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study. Am. J. Surg. Pathol. 1999;23: 963-969.
60. Eppert K, Scherer SW, Ozcelik H et al. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 1996; 86: 543-552.
61. Riggins GJ, Thiagalingam S, Rozenblum E et al. Mad-related genes in the human. Nat. Genet. 1996;13: 347-349.
62. Willenbucher RF, Aust DE, Chang CG et al. Genomic instability is an early event during the progression pathway of ulcerative colitis-related neoplasia. Am. J. Pathol. 1999;154: 1825-1830.
63. Suzuki H, Harpaz N, Tarmin L et al. Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers. Cancer Res. 1994;54: 4841-4844.
64. Brentnall TA, Crispin DA, Bronner MP et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res. 1996;56: 1237-1240.
65. Cawkwell L, Sutherland F, Murgatroyd H et al. Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis-associated colorectal cancers. Gut 2000;46: 367-369.
66. Boland CR, Thibodeau SN, Hamilton SR et al. National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58: 5248-5257.
67. Herman JG, Merlo A, Mao L et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995;55: 4525-4530.
68. Cairns P, Polascik TJ, Eby Y et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet. 1995;11: 210-212.
69. Ohhara M, Esumi M, Kurosu Y. Activation but not inactivation of the MTS1 gene is associated with primary colorectal carcinomas. Biochem. Biophys. Res. Commun. 1996;226: 791-795.
70. Gonzalez-Zulueta M, Bender CM, Yang AS et al. Methylation of the 5′-CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 1995;55: 4531-4535.
71. Hsieh CJ, Klump B, Holzmann K, Borchard F, Gregor M, Porschen R. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res. 1998;58: 3942-3945.
72. Greenstein AJ, Gennuso R, Sachar DB et al. Extraintestinal cancers in inflammatory bowel disease. Cancer 1985; 56: 2914-2921.
73. Baker D, Chiprut RO, Rimer D, Lewin KJ, Rosenberg MZ. Colonic lymphoma in ulcerative colitis. J. Clin. Gastroenterol. 1985;7: 379-386.
74. Shepherd NA, Hall PA, Williams GT et al. Primary malignant lymphoma of the large intestine complicating chronic inflammatory bowel disease. Histopathology 1989;15: 325-337.
75. Greenstein AJ, Mullin GE, Strauchen JA et al. Lymphoma in inflammatory bowel disease. Cancer 1992;69: 1119-1123.
76. Dodd SM. Chronic ulcerative colitis complicated by atypical carcinoid tumor. J. Clin. Pathol. 1986;39: 913-916.
77. Farr CM, Rajala WP. Carcinoid tumor complicating ulcerative colitis. Gastrointest. Endosc. 1990;36: 315-316.
78. McNeely B, Owen DA, Pezim M. Multiple microcarcinoids arising in chronic ulcerative colitis. Am. J. Clin. Pathol. 1992;98: 112-116.
79. Gledhill A, Hall PA, Cruse JP, Pollock DJ. Enteroendocrine cell hyperplasia, carcinoid tumors and adenocarcinoma in longstanding ulcerative colitis. Histopathology 1986;10: 501-508.
80. Gordon HW, Rywlin AM. Kaposi's sarcoma of the large intestine associated with ulcerative colitis. Gastroenterology 1966;50: 248-253.
81. Converse CF, Reagan JW, DeCosse JJ. Ulcerative colitis and carcinoma of the bile ducts. Am. J. Surg. 1971;121: 39-45.
82. Ritchie JK, Allan RN, MacArtney J, Thompson H, Hawley PR, Cooke WT. Biliary tract carcinoma associated with ulcerative colitis. Am. J. Med. 1974;43: 263-279.